Healthcare -
Biotechnology - NASDAQ - US
$ 0.2625
-3.42 %
$ 16.9 M
Market Cap
-0.44
P/E
GLYC - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity GLYC - GlycoMimetics, Inc.
11.1 B
LAST VALUE
1363.13%
2 YEAR CAGR
131.18%
5 YEAR CAGR
69.32%
10 YEAR CAGR